CHGCY vs ABBV: Which Stock is Better?

Side-by-side comparison of Chugai Pharmaceutical Co Ltd ADR and AbbVie Inc in 2026

Comparison Updated:

CHGCY

Chugai Pharmaceutical Co Ltd ADR

ABBV

AbbVie Inc

$244.11

Key Metrics Comparison

MetricCHGCYABBVWinner
Market Cap$77.97B$334.34BABBV
P/E Ratio27.5480.54CHGCY
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze CHGCY

Full quant analysis

Analyze ABBV

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CHGCY or ABBV a better investment?

Comparing CHGCY and ABBV: Chugai Pharmaceutical Co Ltd ADR has a market cap of $77.97B while AbbVie Inc has $334.34B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CHGCY and ABBV?

CHGCY (Chugai Pharmaceutical Co Ltd ADR) and ABBV (AbbVie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CHGCY or ABBV?

Based on P/E ratios, CHGCY trades at a lower multiple (27.5x vs 80.5x).

Which is growing faster: CHGCY or ABBV?

Both CHGCY and ABBV show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: CHGCY or ABBV?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: CHGCY or ABBV?

AbbVie Inc (ABBV) is larger with a market cap of $334.34B compared to $77.97B for CHGCY.

Should I buy CHGCY or ABBV in 2026?

Both CHGCY and ABBV have investment merit. CHGCY trades at $N/A while ABBV trades at $244.11. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CHGCY and ABBV stock?

Key differences: Market Cap ($77.97B vs $334.34B), P/E Ratio (27.5x vs 80.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy CHGCY or ABBV in 2026?

The choice between CHGCY and ABBV depends on your investment goals. ABBV shows higher revenue growth (0.0%). ABBV has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between CHGCY and ABBV?

CHGCY (Chugai Pharmaceutical Co Ltd ADR) has a market cap of $77.97B, while ABBV (AbbVie Inc) has a market cap of $334.34B. ABBV is the larger company by market value.

Popular Stock Comparisons